Destriazolyl bromo propiconazole

CAS: 60207-89-8

Ref. 3D-KCA20789

Produktinformation

• Name: Destriazolyl bromo propiconazole
• Synonyme: 1,3-Dioxolane, 2-(bromomethyl)-2-(2,4-dichlorophenyl)-4-propyl-, 2-Bromomethyl-2-(2,4-dichlorophenyl)-4-propyldioxolane, Bromoketal

Beschreibung

Destriazolyl bromo propiconazole is a medicinal analog that has shown potent anticancer properties. It acts as an inhibitor of protein kinases, which are enzymes involved in cell cycle regulation and tumor growth. This compound induces apoptosis in cancer cells and inhibits their proliferation, making it a promising candidate for cancer therapy. Destriazolyl bromo propiconazole has been tested on Chinese hamster ovary cells and human urine samples, showing promising results as a potential tumor inhibitor. Its mechanism of action involves binding to the active site of the kinase enzyme, blocking its activity and preventing cancer cell growth.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 354.1 g/mol
• Formel: C₁₃H₁₅BrCl₂O₂
• Reinheit: Min. 95%